Recombinant viruses encoding the human melanoma-associated antigen
US5262177A · kind A · utility
61Cited by
2References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 1987 |
| Grant date | Nov 16, 1993 |
| Priority date | — |
| Expiry date | Jan 27, 2007 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5743
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptides or proteins related to a melanoma associated antigen are described. These are produced in large quantities via recombinant DNA techniques and/or by chemical synthetic methods. The peptides or proteins can be used as immunogens in vaccine formulations which can induce an immune response that selectively destroys melanoma cells in a vaccinated individual. Where the peptides or proteins are expressed by a recombinant virus, inactivated or live virus vaccine formulations may be prepared.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.